Nexus Investment Management Ulc Viatris Inc Transaction History

Nexus Investment Management Ulc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 13, 2022	SELL	$12.09 - $14.68 $345,193 - $419,143	-28,552 Closed	0 $0
Q3 2021 Oct 07, 2021	SELL	$13.25 - $15.13 $660,777 - $754,533	-49,870 Reduced 63.59%	28,552 $387,000
Q2 2021 Jul 13, 2021	SELL	$12.97 - $16.15 $141,801 - $176,567	-10,933 Reduced 12.24%	78,422 $1.12 Million
Q1 2021 Apr 09, 2021	SELL	$13.59 - $18.54 $842 - $1,149	-62 Reduced 0.07%	89,355 $1.25 Million
Q4 2020 Jan 11, 2021	BUY	$14.3 - $18.74 $1.28 Million - $1.68 Million	89,417 New	89,417 $1.59 Million

1,102

933M

2.71M

2.4M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Nexus Investment Management Ulc, based on Form 13F filings with the SEC.

Stay updated on Nexus Investment Management Ulc with notifications on news.